Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kubasch, Anne Sophie (VerfasserIn) , Peterlin, P. (VerfasserIn) , Cluzeau, T. (VerfasserIn) , Götze, K. S. (VerfasserIn) , Sockel, K. (VerfasserIn) , Teipel, R. (VerfasserIn) , Jentzsch, M. (VerfasserIn) , Attalah, H. (VerfasserIn) , Sebert, M. (VerfasserIn) , Chermat, F. (VerfasserIn) , Gloaguen, S. (VerfasserIn) , Puttrich, M. (VerfasserIn) , Cross, M. (VerfasserIn) , Schneider, M. (VerfasserIn) , Kayser, Sabine (VerfasserIn) , Schipp, D. (VerfasserIn) , Giagounidis, A. (VerfasserIn) , Tirado-Gonzalez, I. (VerfasserIn) , Descot, A. (VerfasserIn) , van de Loosdrecht, A. (VerfasserIn) , Weigert, A. (VerfasserIn) , Metzeler, K. H. (VerfasserIn) , Fenaux, P. (VerfasserIn) , Medyouf, H. (VerfasserIn) , Platzbecker, Uwe (VerfasserIn) , Ades, L. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 21 September 2023
In: Leukemia
Year: 2023, Jahrgang: 37, Heft: 11, Pages: 2309-2313
ISSN:1476-5551
DOI:10.1038/s41375-023-02029-1
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-023-02029-1
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-023-02029-1
Volltext
Verfasserangaben:A.S. Kubasch, P. Peterlin, T. Cluzeau, K.S. Götze, K. Sockel, R. Teipel, M. Jentzsch, H. Attalah, M. Sebert, F. Chermat, S. Gloaguen, M. Puttrich, M. Cross, M. Schneider, S. Kayser, D. Schipp, A. Giagounidis, I. Tirado-Gonzalez, A. Descot, A. van de Loosdrecht, A. Weigert, K.H. Metzeler, P. Fenaux, H. Medyouf, U. Platzbecker and L. Ades

MARC

LEADER 00000caa a2200000 c 4500
001 1873043244
003 DE-627
005 20250115024125.0
007 cr uuu---uuuuu
008 231211s2023 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-023-02029-1  |2 doi 
035 |a (DE-627)1873043244 
035 |a (DE-599)KXP1873043244 
035 |a (OCoLC)1425208407 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kubasch, Anne Sophie  |d 1992-  |e VerfasserIn  |0 (DE-588)1135995443  |0 (DE-627)891059164  |0 (DE-576)490247199  |4 aut 
245 1 0 |a Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial  |c A.S. Kubasch, P. Peterlin, T. Cluzeau, K.S. Götze, K. Sockel, R. Teipel, M. Jentzsch, H. Attalah, M. Sebert, F. Chermat, S. Gloaguen, M. Puttrich, M. Cross, M. Schneider, S. Kayser, D. Schipp, A. Giagounidis, I. Tirado-Gonzalez, A. Descot, A. van de Loosdrecht, A. Weigert, K.H. Metzeler, P. Fenaux, H. Medyouf, U. Platzbecker and L. Ades 
264 1 |c 21 September 2023 
300 |b Illustrationen 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 21. September 2023 
500 |a Gesehen am 11.12.2023 
650 4 |a Myelodysplastic syndrome 
700 1 |a Peterlin, P.  |e VerfasserIn  |4 aut 
700 1 |a Cluzeau, T.  |e VerfasserIn  |4 aut 
700 1 |a Götze, K. S.  |e VerfasserIn  |4 aut 
700 1 |a Sockel, K.  |e VerfasserIn  |4 aut 
700 1 |a Teipel, R.  |e VerfasserIn  |4 aut 
700 1 |a Jentzsch, M.  |e VerfasserIn  |4 aut 
700 1 |a Attalah, H.  |e VerfasserIn  |4 aut 
700 1 |a Sebert, M.  |e VerfasserIn  |4 aut 
700 1 |a Chermat, F.  |e VerfasserIn  |4 aut 
700 1 |a Gloaguen, S.  |e VerfasserIn  |4 aut 
700 1 |a Puttrich, M.  |e VerfasserIn  |4 aut 
700 1 |a Cross, M.  |e VerfasserIn  |4 aut 
700 1 |a Schneider, M.  |e VerfasserIn  |4 aut 
700 1 |a Kayser, Sabine  |d 1979-  |e VerfasserIn  |0 (DE-588)138694923  |0 (DE-627)605256233  |0 (DE-576)30778813X  |4 aut 
700 1 |a Schipp, D.  |e VerfasserIn  |4 aut 
700 1 |a Giagounidis, A.  |e VerfasserIn  |4 aut 
700 1 |a Tirado-Gonzalez, I.  |e VerfasserIn  |4 aut 
700 1 |a Descot, A.  |e VerfasserIn  |4 aut 
700 1 |a van de Loosdrecht, A.  |e VerfasserIn  |4 aut 
700 1 |a Weigert, A.  |e VerfasserIn  |4 aut 
700 1 |a Metzeler, K. H.  |e VerfasserIn  |4 aut 
700 1 |a Fenaux, P.  |e VerfasserIn  |4 aut 
700 1 |a Medyouf, H.  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
700 1 |a Ades, L.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 37(2023), 11, Seite 2309-2313  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial 
773 1 8 |g volume:37  |g year:2023  |g number:11  |g pages:2309-2313  |g extent:5  |a Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial 
856 4 0 |u https://doi.org/10.1038/s41375-023-02029-1  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-023-02029-1  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20231211 
993 |a Editorial 
994 |a 2023 
998 |g 138694923  |a Kayser, Sabine  |m 138694923:Kayser, Sabine  |d 60000  |d 63500  |e 60000PK138694923  |e 63500PK138694923  |k 0/60000/  |k 1/60000/63500/  |p 15 
999 |a KXP-PPN1873043244  |e 4430608563 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1038/s41375-023-02029-1"],"eki":["1873043244"]},"physDesc":[{"extent":"5 S.","noteIll":"Illustrationen"}],"title":[{"title":"Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial","title_sort":"Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"21 September 2023"}],"relHost":[{"note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"language":["eng"],"part":{"text":"37(2023), 11, Seite 2309-2313","extent":"5","pages":"2309-2313","issue":"11","volume":"37","year":"2023"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trialLeukemia","recId":"32046699X","origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32046699X"],"issn":["1476-5551"],"zdb":["2008023-2"]}}],"language":["eng"],"name":{"displayForm":["A.S. Kubasch, P. Peterlin, T. Cluzeau, K.S. Götze, K. Sockel, R. Teipel, M. Jentzsch, H. Attalah, M. Sebert, F. Chermat, S. Gloaguen, M. Puttrich, M. Cross, M. Schneider, S. Kayser, D. Schipp, A. Giagounidis, I. Tirado-Gonzalez, A. Descot, A. van de Loosdrecht, A. Weigert, K.H. Metzeler, P. Fenaux, H. Medyouf, U. Platzbecker and L. Ades"]},"note":["Online veröffentlicht: 21. September 2023","Gesehen am 11.12.2023"],"recId":"1873043244","person":[{"role":"aut","family":"Kubasch","given":"Anne Sophie","display":"Kubasch, Anne Sophie"},{"family":"Peterlin","role":"aut","display":"Peterlin, P.","given":"P."},{"display":"Cluzeau, T.","given":"T.","family":"Cluzeau","role":"aut"},{"role":"aut","family":"Götze","display":"Götze, K. S.","given":"K. S."},{"display":"Sockel, K.","given":"K.","role":"aut","family":"Sockel"},{"display":"Teipel, R.","given":"R.","family":"Teipel","role":"aut"},{"role":"aut","family":"Jentzsch","display":"Jentzsch, M.","given":"M."},{"given":"H.","display":"Attalah, H.","role":"aut","family":"Attalah"},{"role":"aut","family":"Sebert","display":"Sebert, M.","given":"M."},{"display":"Chermat, F.","given":"F.","role":"aut","family":"Chermat"},{"given":"S.","display":"Gloaguen, S.","family":"Gloaguen","role":"aut"},{"display":"Puttrich, M.","given":"M.","role":"aut","family":"Puttrich"},{"family":"Cross","role":"aut","given":"M.","display":"Cross, M."},{"given":"M.","display":"Schneider, M.","role":"aut","family":"Schneider"},{"given":"Sabine","display":"Kayser, Sabine","role":"aut","family":"Kayser"},{"display":"Schipp, D.","given":"D.","family":"Schipp","role":"aut"},{"role":"aut","family":"Giagounidis","given":"A.","display":"Giagounidis, A."},{"given":"I.","display":"Tirado-Gonzalez, I.","role":"aut","family":"Tirado-Gonzalez"},{"given":"A.","display":"Descot, A.","role":"aut","family":"Descot"},{"given":"A.","display":"van de Loosdrecht, A.","role":"aut","family":"van de Loosdrecht"},{"display":"Weigert, A.","given":"A.","family":"Weigert","role":"aut"},{"family":"Metzeler","role":"aut","given":"K. H.","display":"Metzeler, K. H."},{"role":"aut","family":"Fenaux","display":"Fenaux, P.","given":"P."},{"family":"Medyouf","role":"aut","given":"H.","display":"Medyouf, H."},{"family":"Platzbecker","role":"aut","given":"Uwe","display":"Platzbecker, Uwe"},{"display":"Ades, L.","given":"L.","family":"Ades","role":"aut"}]} 
SRT |a KUBASCHANNEFFICACYAN2120